Cargando…

Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence

Detalles Bibliográficos
Autores principales:	McKeown, Pascal P, Muir, Alison Rachel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607114/ https://www.ncbi.nlm.nih.gov/pubmed/23376948 http://dx.doi.org/10.1136/heartjnl-2012-303363

Ejemplares similares

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy
por: Packard, Elizabeth, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy in Adolescence: Application of Guidelines
por: Kantor, Paul F., et al.
Publicado: (2020)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review
por: Lebowitz, Steven, et al.
Publicado: (2022)

Left Ventricular Thrombus in Hypertrophic Cardiomyopathy
por: Hamada, Mareomi
Publicado: (2018)

Genetic and Molecular Mechanisms of Hypertrophic Cardiomyopathy
por: Chou, Chun, et al.
Publicado: (2023)

Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy
por: Schindler, Thomas H., et al.
Publicado: (2020)

A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
por: Iacovoni, Attilio, et al.
Publicado: (2012)

Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance( )
por: Huurman, Roy, et al.
Publicado: (2022)

Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging
por: Kitai, Takeshi, et al.
Publicado: (2022)

Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy
por: Siontis, Konstantinos C., et al.
Publicado: (2019)

Hypertrophic Cardiomyopathy—Current Challenges and Future Perspectives
por: Monda, Emanuele, et al.
Publicado: (2023)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2019)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
por: Gragnano, Felice, et al.
Publicado: (2023)

Hypertrophic Cardiomyopathy: A Cardiovascular Challenge Becoming a Contemporary Treatable Disease
por: Sakellaropoulos, Stefanos G., et al.
Publicado: (2023)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy
por: Minami, Yuichiro, et al.
Publicado: (2018)

Emergence of endocardium/epicardium flow gradient as novel risk biomarker in patients with hypertrophic cardiomyopathy
por: Schindler, Thomas H., et al.
Publicado: (2020)

Atrial Function Assessment in High-Risk Hypertrophic Cardiomyopathy
por: Mulia, Eka Prasetya Budi, et al.
Publicado: (2023)

Role of the Extracellular Matrix in the Pathogenesis of Hypertrophic Cardiomyopathy
por: Marian, Ali J.
Publicado: (2019)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

The consolidation of surgery for hypertrophic obstructive cardiomyopathy in Asia and the Pacific Rim
por: Quintana, Eduard, et al.
Publicado: (2021)

Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
por: Lafreniere-Roula, Myriam, et al.
Publicado: (2019)

Commentary: Endocarditis in hypertrophic cardiomyopathy: A reason to strengthen the guidelines?
por: Carrel, Thierry
Publicado: (2020)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?
por: Sara, Leonardo
Publicado: (2019)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Ventricular Arrhythmias in Hypertrophic Cardiomyopathy- Can We Ever Predict Them?
por: Namboodiri, Narayanan, et al.
Publicado: (2010)

Will the Mitral Clip become the invasive treatment of choice for hypertrophic obstructive cardiomyopathy?
por: Alkhouli, Mohamad
Publicado: (2014)

Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin
por: Sau, Arunashis, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

PRISMA guideline compliance is imperative for systematic review appraisal
por: McKeown, Sandra
Publicado: (2020)

Poor Quality Embryos Hamper the Development of High Quality Ones
por: Sadeghi, Mohammad Reza
Publicado: (2017)

Risk stratification in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2018)

New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?
por: van der Wall, E. E.
Publicado: (2014)

C25 in QUB: a transformed curriculum for a transformed healthcare system
por: Kennedy, Neil, et al.
Publicado: (2021)

Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion
por: Pandian, Natesa G, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uq26epi8btmbfev9qbc3do3e6n